DIAMEDICA THERAPEUTICS INC (DMAC)
CA25253X2077 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -19.38M | -13.68M | -13.59M | -12.29M | -10.65M | |||
| Depreciation Amortization | 30.00K | 30.00K | 20.00K | 20.00K | 20.00K | |||
| Change In Working Capital | 93.00K | 590.00K | -460.00K | 1.20M | 390.00K | |||
| Interest Paid | N/A | N/A | N/A | 0.00 | 0.00 | |||
| Taxes Paid | 33.00K | 30.00K | 30.00K | 40.00K | 30.00K | |||
| Other non cash items | 530.00K | 1.56M | 1.78M | 1.89M | 1.14M | |||
| OPERATING CASH FLOW | -18.73M | -11.51M | -12.25M | -9.19M | -9.10M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -24.00K | -80.00K | -20.00K | -50.00K | 0.00 | |||
| Other Investing Activity | -18.27M | 11.62M | -20.52M | -16.09M | -3.91M | |||
| INVESTING CASH FLOW | -18.30M | 11.54M | -20.54M | -16.13M | -3.91M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | -6.00K | -10.00K | -10.00K | -10.00K | -10.00K | |||
| Stock Issued/Repurchased | 36.85M | 0.00 | 30.09M | 28.85M | 80.00K | |||
| FINANCING CASH FLOW | 36.84M | -10.00K | 30.09M | 28.85M | 70.00K | |||
| Exchange Rate Effect | N/A | N/A | N/A | N/A | N/A | |||
| CHANGE IN CASH | -185.00K | 20.00K | -2.70M | 3.53M | -12.94M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -18.73M | -11.51M | -12.25M | -9.19M | -9.10M | |||
| Capital Expenditure | -24.00K | -80.00K | -20.00K | -50.00K | 0.00 | |||
| FREE CASH FLOW | -18.75M | -11.59M | -12.27M | -9.24M | -9.10M | |||
All data in USD